In a recent study, MHC class II expression of Th1 cells was blocked by IL-6, hampering the secretion of IFN-γ and IL-2, thereby reducing the cytotoxic T-lymphocyte activity, enabling the cancer cells to evade the anticancer immunological reaction [37]. Here, IL6 is linked to cancer.